Olivia M Merkel
Affiliations: | LMU Munich, Germany, München, Bayern, Germany |
Area:
Drug and Gene DeliveryGoogle:
"Olivia Merkel"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Lea-Adriana Barlang (née Keller) | grad student | 2020- | LMU Munich, Germany |
| Maha Elsayed | grad student | 2011-2013 | Wayne State |
| Ying Li | grad student | 2014-2016 | Wayne State |
| Steven K Jones | grad student | 2012-2017 | Wayne State University School of Medicine |
| Yuran Xie | grad student | 2012-2017 | Wayne State |
| Daniel P Feldmann | grad student | 2013-2017 | Wayne State University School of Medicine |
| Bettina Gabold (née Schwarz) | grad student | 2015-2017 | LMU Munich, Germany |
| Domizia Baldassi | grad student | 2018-2018 | LMU Munich, Germany |
| Rima Kandil | grad student | 2016-2019 | LMU Munich, Germany |
| Matteo Petrini | grad student | 2016-2019 | LMU Munich, Germany |
| Johannes Bader | grad student | 2017-2019 | LMU Munich, Germany |
| Tobias Keil | grad student | 2016-2020 | LMU Munich, Germany |
| Patrick Strack | grad student | 2017-2021 | LMU Munich, Germany |
| Natascha Hartl | grad student | 2017-2022 | LMU Munich, Germany |
| Yao Jin | grad student | 2019-2022 | LMU Munich, Germany |
| Christoph M. Zimmermann | grad student | 2019-2022 | LMU Munich, Germany |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gabold B, Adams F, Brameyer S, et al. (2022) Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins. Drug Delivery and Translational Research |
| Zimmermann CM, Baldassi D, Chan K, et al. (2022) Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 351: 137-150 |
| Baldassi D, Ambike S, Feuerherd M, et al. (2022) Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes. Journal of Controlled Release : Official Journal of the Controlled Release Society. 345: 661-674 |
| Conte G, Costabile G, Baldassi D, et al. (2022) Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference? Acs Applied Materials & Interfaces. 14: 7565-7578 |
| Ambike S, Cheng CC, Feuerherd M, et al. (2021) Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread. Nucleic Acids Research |
| Baldassi D, Gabold B, Merkel O. (2021) Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions. Advanced Nanobiomed Research. 1 |
| Keil TW, Zimmermann C, Baldassi D, et al. (2021) Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles. Advanced Therapeutics. 4 |
| Petrini M, Lokerse WJM, Mach A, et al. (2021) Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes. International Journal of Nanomedicine. 16: 4045-4061 |
| Hartl N, Adams F, Merkel OM. (2021) From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier. Advanced Therapeutics. 4 |
| Feldmann DP, Heyza J, Zimmermann CM, et al. (2020) Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy. Molecules (Basel, Switzerland). 25 |